D

DiagnosTear Technologies
DTR

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
CA$31.30M
EV
-
Shares Outstanding
60.19M
Beta
-
Industry
-

Wall Street View

Analyst Rating
-
Analyst Target Price
-
Number of Analysts
0
P/E E
-
P/Revenue E
-

Historical 3Y Growth Rate

Revenue
-
EPS
-
Operating Cash Flow
-
Free Cash Flow
-

Forecasted 3Y Growth Rate

Revenue
-
EPS
-
Operating Cash Flow
-
Free Cash Flow
-

Margins & Returns

Gross Margin E
-
Net Profit Margin E
-
ROE E
-
ROCE
-

Dividends

DPS E
-
Payout Ratio E
-
Div. Yield E
-
DPS Last 3Y CAGR
-

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About DiagnosTear Technologies Inc.

gainify

D

DiagnosTear Technologies Inc.

DTR

DiagnosTear Technologies Inc., an ophthalmic company, engages in developing and commercializing disruptive diagnostic solutions for eye diseases. It develops TeaRx Dry Eye, a CE-IVD approved test based on the TeaRx platform intended for the identification and monitori...

Sector

Industry

CEO

Gross, Shimon

Employees

IPO Date

Headquarters

10 Menachem Plaut Street, Rehovot 7670621, Israel

💰 Financial Metrics & Reports

The current DiagnosTear Technologies (DTR) market capitalization is approximately CA$31.30M, based on its latest share price and shares outstanding. Market capitalization represents the total market value of a company's equity and is calculated by multiplying the current stock price by the number of shares outstanding. As a result, DiagnosTear Technologies's market cap fluctuates with changes in its share price and share count. Last updated: December 31, 2025 at 11:42 PM Eastern Time

📅 Earnings & Dividends

DiagnosTear Technologies (DTR) does not currently pay a dividend. Over the last twelve months (LTM), the company paid CA$0.00 per share in dividends, and no dividend payments are currently expected over the next twelve months (NTM). Companies that do not pay dividends typically prioritize reinvesting cash into growth initiatives, capital expenditures, debt reduction, or strategic investments, though dividend policy may change in the future.

📈 Analyst Information

Based on the latest available analyst coverage, DiagnosTear Technologies (DTR) currently carries a not available consensus rating. Analyst views are forward-looking estimates and should not be considered investment advice.

Like other publicly traded stocks, DiagnosTear Technologies (DTR) shares are bought and sold on stock exchanges such as CNSX and other supported markets, depending on the listing. The most common way to buy shares is through an online brokerage account. To get started, you typically need to: Open an account with a licensed stock brokerComplete the broker's verification processFund your accountPlace a buy order for DiagnosTear Technologies (DTR) shares Trading involves risk, and investors should consider their financial objectives and risk tolerance before investing.

ℹ️ Company Information

At the top right of this page, you'll see a star icon labeled Add to watchlist. Click it to add DTR to your watchlist.

DiagnosTear Technologies trades under the ticker symbol DTR on the CNSX stock exchange. The ticker DTR is used to identify the company's common stock across trading platforms, market data providers, and regulatory filings.

gainifypowered-by-sp
Socials
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on TrustpilotFollow us on YouTubeFind us on Google Maps

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2026 Gainify. All rights reserved.